Fundraising Fox

Michael Dixon

Investor

Principal at Sanderling Ventures

About

A CPA/CA with over 18 years in executive roles at venture-backed companies, currently CEO of Therillia Development Company. He previously served as CFO of Gemin X Pharmaceuticals (sold to Cephalon/Teva) and held finance leadership roles at Morphometrix Technologies, beginning his career at Price Waterhouse.

Colleagues at Sanderling Ventures

Benjamin F. McGraw III
Venture Partner at Sanderling Ventures
Fred Middleton
Managing Director at Sanderling Ventures
Paulette Taylor
General Counsel & Principal at Sanderling Ventures
Peter McWilliams
Venture Partner at Sanderling Ventures
Pierre Beauparlant
Venture Partner at Sanderling Ventures
Robert G. McNeil
Founding Partner at Sanderling Ventures
Timothy Mills
Managing Director at Sanderling Ventures
Timothy Wollaeger
Managing Director Emeritus at Sanderling Ventures